BMJ Editorial: HRT and breast cancer risk: we must prevent another setback in women’s health
Review of the data published in the Lancet last Friday, 11 October 2019.
BMS Response to the Government’s new measures to tackle HRT shortages
The British Menopause Society welcomes the Government’s new measures that restrict exporting hormone replacement therapy (HRT) outside the UK.
British Menopause Society further update on HRT supply shortages (23rd September 2019)
The British Menopause Society has produced this further update on the current availability of HRT products in response to the ongoing HRT shortages. The objective of this is to provide guidance to BMS members and clinical practitioners who may be experiencing difficulties with HRT supplies.
BMS response to MHRA recommendations
The medical advisory council of the BMS has reviewed the recommendations issued by the Medicines and Healthcare Products Regulatory Agency (MHRA) on 30 August. The following letter was sent to Dr June Raine, interim CEO of the MHRA.
Joint RCOG & BMS statement in response to the Lancet study on HRT use and breast cancer risk
A study published in The Lancet shows the risk of breast cancer with hormone replacement therapy (HRT) in relation to the type and timing of hormonal intake.
BMS response to Lancet paper on the link between different forms of HRT and breast cancer incidence
A meta-analysis published in the Lancet this week by the Collaborative Group on Hormonal Factors in Breast Cancer reported on the risk of breast cancer with HRT in relation to the type and timing of hormonal intake.
Joint RCOG / BMS / FSRH position on ongoing HRT shortages
The Royal College of Obstetricians and Gynaecologists (RCOG), the British Menopause Society (BMS) and the Faculty of Sexual and Reproductive Health care (FSRH) are receiving multiple queries from women who are unable to access their hormone replacement therapy (HRT) products due to ongoing manufacturing and supply issues.
British Menopause Society further update on HRT supply shortages
In response to the ongoing HRT shortages, the British Menopause Society has produced this further update on the current availability of HRT products. This provides guidance to BMS members and clinical practitioners who may be experiencing difficulties with HRT supplies.
British Menopause Society update on HRT supply shortages
In response to the recent reports of HRT shortages, the British Menopause Society has produced this update on the current availability of HRT products.
New medical procedure could delay menopause by twenty years – BMS response
The BMS medical advisory council has issued a response to the recent coverage on delaying the menopause: A number of media outlets have reported this week on the launch of a procedure that is intended to delay the menopause by offering women cryopreservation (freezing) of their ovarian tissue with the intention of subsequently replacing the [...]